Genscript Biotech Corporation (G51) — Free Cash Flow Generation Index
Genscript Biotech Corporation (G51) has a Free Cash Flow Generation Index of 1.00x as of December 2019. Free cash flow of €61.62 Million represents 1% of operating cash flow (€61.62 Million). Explore Genscript Biotech Corporation (G51) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genscript Biotech Corporation Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Genscript Biotech Corporation across 5 annual periods. For the full cash flow conversion analysis, see Genscript Biotech Corporation cash flow conversion.
Annual Free Cash Flow Generation for Genscript Biotech Corporation (2016–2025)
Year-by-year Free Cash Flow Generation Index for Genscript Biotech Corporation. Check Genscript Biotech Corporation (G51) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €241.69 Million | €325.52 Million | €83.84 Million | ▲ +177.7% |
| 2024 | -0.96x | €-72.27 Million | €75.65 Million | €147.92 Million | ▼ -236.2% |
| 2018 | 0.70x | €215.80 Million | €307.66 Million | €70.84 Million | ▲ +241.4% |
| 2017 | -0.50x | €-10.60 Million | €21.37 Million | €29.21 Million | ▼ -139.1% |
| 2016 | 1.27x | €42.26 Million | €33.27 Million | €8.98 Million | — |